Sponsor:
Pfizer
Code:
NCT07859527
Conditions
Hemophilia
Eligibility Criteria
Sex: All
Age: 6+
Healthy Volunteers: Not accepted
Interventions
Marstacimab
Brief summary:
Conditions
Hemophilia
Study ID
NCT07859527
Start date
Nov 16, 2026
Status verified date
Nov, 2026
Completion date
Aug 30, 2028
Anticipated
Primary completion date
Aug 30, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 6+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Arms
Real World Data participants
Interventions
Marstacimab
Primary outcome measure
Central contacts
Locations
Pfizer
Recruiting
New York, New York, United States, 10001
Sponsor
Pfizer
Last update posted
Nov 17, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by Pfizer on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.